Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,978 GBX | +5.51% | +10.13% | +13.40% |
03:40pm | ASTRAZENECA : UBS maintains a Sell rating | ZD |
03:22pm | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.40% | 219B | |
+24.35% | 562B | |
-6.44% | 358B | |
+19.33% | 322B | |
+7.49% | 297B | |
+6.03% | 199B | |
-10.43% | 196B | |
-10.96% | 149B | |
-6.90% | 146B | |
+1.93% | 117B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Says Calquence Demonstrated Favorable Benefit-Risk Profile as Treatment for Chronic Lymphocytic Leukemia